ArticleFrontiers in medicine2025

Efficacy and safety of sofosbuvir plus daclatasvir in hemodialysis patients with genotype 1b or 2a hepatitis C virus infection: a single-arm, prospective real-world study.

Kaili Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.